Lianhe Pharmaceutical (600513.SH): The raw material drug product Levonorgestrel has passed the pre-qualification of the World Health Organization.

The Securities Times app news: LianHuan Pharmaceutical (600513.SH) announced that the company recently received a notification from the World Health Organization (WHO) that their active pharmaceutical ingredient Levonorgestrel (APIMF484, WHOAPI-484) has passed the World Health Organization's pre-qualification (PQ). The World Health Organization has officially included the product in the procurement scope of international organizations and public institutions.